NCT00045981View on ClinicalTrials.gov

The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity)

PHASE2CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

May 31, 2003

Study Completion Date

August 31, 2006

Conditions
Hypertension
Interventions
DRUG

ALT-711

All Listed Sponsors
lead

Synvista Therapeutics, Inc

INDUSTRY

NCT00045981 - The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity) | Biotech Hunter | Biotech Hunter